Published in

Taylor and Francis Group, Leukemia & Lymphoma, 4(50), p. 571-581, 2009

DOI: 10.1080/10428190902785528

Links

Tools

Export citation

Search in Google Scholar

Identification of biological markers of sensitivity to high-clinical-risk-adapted therapy for patients with diffuse large B-cell lymphoma

Journal article published in 2009 by Ana I. Sáez, Mónica García-Cosío, Antonio J. Sáez ORCID, Jesús M. Hernández ORCID, Lidia Sánchez-Verde, David Álvarez, Paloma de la Cueva, Reyes Arranz, Eulogio Conde, Carlos Grande, José Rodríguez, Dolores Caballero, Miguel Á. Piris
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO